We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Filter Device for Particles Released During Angioplasty

By HospiMedica staff writers
Posted on 14 Jan 2002
A small basket-like filtering device is designed to capture particles in the blood that may be released during angioplasty. More...
The device allows blood to flow through it while capturing the particles.

The device is for use in patients who have had prior heart bypass surgery and whose bypass grafts have subsequently narrowed. Over time, arterial pressures degrade the vein grafts so they fill up and are clogged with plaque. A catheter is used to thread the basket filter through an artery and position it in the vein graft just beyond the blockage. The basket filter collapses within the catheter for positioning and resumes its shape when placed in the vein graft. The cardiologist then opens the narrowing in the artery with balloon angioplasty and places a stent in the narrowing to keep it open. The basket and contents are collapsed into a retrieval catheter. The plaque debris from the basket is later analyzed by a pathologist.

The effectiveness of the filter will be tested in a research study against a currently used balloon device by researchers at the University of Pittsburgh Medical Center (PA, USA). In this device, blood flow is stopped. An earlier study found that 8% of patients undergoing angioplasty with balloon protection had a cardiac event (death, heart attack, stent closure), while those without balloon protection had an event rate of 15%. The study of 800 patients is sponsored by MedNova (Galway, Ireland), the manufacturer of the basket device, called the CardioShield.




Related Links:
Univ. of Pittsburgh

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.